Your browser doesn't support javascript.
loading
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statement.
Apalla, Z; Nikolaou, V; Fattore, D; Fabbrocini, G; Freites-Martinez, A; Sollena, P; Lacouture, M; Kraehenbuehl, L; Stratigos, A; Peris, K; Lazaridou, E; Richert, B; Vigarios, E; Riganti, J; Baroudjian, B; Filoni, A; Dodiuk-Gad, R; Lebbé, C; Sibaud, V.
Afiliação
  • Apalla Z; Second Dermatology Department, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Nikolaou V; First Department of Dermatology, "Andreas Sygros" Hospital for Skin Diseases, National and Kapodestrian University of Athens, Medical School, Athens, Greece.
  • Fattore D; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Fabbrocini G; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Freites-Martinez A; Servicio de Dermatología, Hospital Ruber Juan Bravo y Universidad Europea, Madrid, España.
  • Sollena P; Dipartimento di Scienze Mediche e Chirurgiche, Dermatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Lacouture M; Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Kraehenbuehl L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Stratigos A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Peris K; Parker Institute for Cancer Immunotherapy, Ludwig Collaborative and Swim Across America Laboratory, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Lazaridou E; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Richert B; First Department of Dermatology, "Andreas Sygros" Hospital for Skin Diseases, National and Kapodestrian University of Athens, Medical School, Athens, Greece.
  • Vigarios E; Dipartimento di Scienze Mediche e Chirurgiche, Dermatologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Riganti J; Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Baroudjian B; Second Dermatology Department, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Filoni A; Department of Dermatology, Brugmann & Saint-Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
  • Dodiuk-Gad R; Department of Oral Medicine, Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.
  • Lebbé C; Hospital Italiano of Buenos Aires, Buenos Aires, Argentina.
  • Sibaud V; Dermatology Department, Saint Louis Hospital, Université de Paris, AP-HP, INSERM U976, Paris, France.
J Eur Acad Dermatol Venereol ; 36(3): 332-350, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34910332
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / Dermatologia / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dermatopatias / Dermatologia / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article